SELLAS Life Sciences Group Inc (SLS)
1.17
-0.05
(-4.10%)
USD |
NASDAQ |
Nov 22, 16:00
1.165
0.00 (0.00%)
After-Hours: 20:00
SELLAS Life Sciences Group Enterprise Value: 61.32M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 61.32M |
| November 21, 2024 | 64.84M |
| November 20, 2024 | 66.24M |
| November 19, 2024 | 69.76M |
| November 18, 2024 | 69.76M |
| November 15, 2024 | 71.87M |
| November 14, 2024 | 68.35M |
| November 13, 2024 | 68.35M |
| November 12, 2024 | 73.98M |
| November 11, 2024 | 59.45M |
| November 08, 2024 | 58.16M |
| November 07, 2024 | 53.65M |
| November 06, 2024 | 53.65M |
| November 05, 2024 | 54.94M |
| November 04, 2024 | 54.30M |
| November 01, 2024 | 55.58M |
| October 31, 2024 | 54.94M |
| October 30, 2024 | 55.58M |
| October 29, 2024 | 58.16M |
| October 28, 2024 | 57.52M |
| October 25, 2024 | 58.16M |
| October 24, 2024 | 49.79M |
| October 23, 2024 | 51.08M |
| October 22, 2024 | 53.65M |
| October 21, 2024 | 55.58M |
| Date | Value |
|---|---|
| October 18, 2024 | 60.09M |
| October 17, 2024 | 59.45M |
| October 16, 2024 | 59.45M |
| October 15, 2024 | 56.23M |
| October 14, 2024 | 59.45M |
| October 11, 2024 | 58.80M |
| October 10, 2024 | 56.23M |
| October 09, 2024 | 55.58M |
| October 08, 2024 | 57.52M |
| October 07, 2024 | 60.09M |
| October 04, 2024 | 60.09M |
| October 03, 2024 | 58.80M |
| October 02, 2024 | 58.80M |
| October 01, 2024 | 56.87M |
| September 30, 2024 | 59.45M |
| September 27, 2024 | 71.91M |
| September 26, 2024 | 72.56M |
| September 25, 2024 | 71.91M |
| September 24, 2024 | 68.70M |
| September 23, 2024 | 67.41M |
| September 20, 2024 | 68.70M |
| September 19, 2024 | 69.34M |
| September 18, 2024 | 69.34M |
| September 17, 2024 | 71.91M |
| September 16, 2024 | 74.49M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.532M
Minimum
Apr 02 2020
183.79M
Maximum
Jun 28 2021
49.81M
Average
38.13M
Median
Enterprise Value Benchmarks
| Microbot Medical Inc | 12.26M |
| Alaunos Therapeutics Inc | 2.144M |
| Galectin Therapeutics Inc | 254.19M |
| Oragenics Inc | 2.314M |
| Anavex Life Sciences Corp | 633.73M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.108M |
| Total Expenses (Quarterly) | 7.329M |
| EPS Diluted (Quarterly) | -0.10 |
| Earnings Yield | -58.97% |
| Normalized Earnings Yield | -183.26 |